Trial Profile
Erbitux monotherapy in patients with locoregional non-to-treat hepatocellular carcinomas.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2011
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 26 Jul 2011 New trial record